Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology

Differential Role of Anandamide and 2-Arachidonoylglycerol in Memory and Anxiety-like Responses

(2011) Arnau Busquets-Garcia et al.   BIOLOGICAL PSYCHIATRY

Worsening of Huntington disease phenotype in CB1 receptor knockout mice

(2011) Stéphane Mievis et al.   NEUROBIOLOGY OF DISEASE

Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity

(2011) Robert E. Hampson et al.   NEUROPHARMACOLOGY

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults

(2011) X. Chen et al.   NEUROSCIENCE

Effects of endocannabinoid system modulation on cognitive and emotional behavior

(2011) Claudio Zanettini   Frontiers in Behavioral Neuroscience

Hippocampal expression and distribution of CB1 receptors in the Amazonian rodent Proechimys: An animal model of resistance to epilepsy

(2010) Bruno Henrique Silva Araujo et al.   BRAIN RESEARCH

Inhibition of fatty acid amide hydrolase unmasks CB1receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey

(2010) H Kawahara et al.   BRITISH JOURNAL OF PHARMACOLOGY

A New Generation Fatty Acid Amide Hydrolase Inhibitor Protects Against Kainate-Induced Excitotoxicity

(2010) Vinogran Naidoo et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Homeostatic changes of the endocannabinoid system in Parkinson's disease

(2010) Valerio Pisani et al.   MOVEMENT DISORDERS

Refined homology model of monoacylglycerol lipase: toward a selective inhibitor

(2009) Anna L. Bowman et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality

(2009) Jeannie Hwang et al.   LIFE SCIENCES

BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices

(2009) H. Jourdi et al.   NEUROPHARMACOLOGY

Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo

(2009) J. Z. Long et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dual inhibition of monoamine oxidase B and antagonism of the adenosine A2A receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues

(2008) Judey Pretorius et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System

(2008) Kay Ahn et al.   CHEMICAL REVIEWS

Covalent Inhibitors of Human Monoacylglycerol Lipase: Ligand-Assisted Characterization of the Catalytic Site by Mass Spectrometry and Mutational Analysis

(2008) Nikolai Zvonok et al.   CHEMISTRY & BIOLOGY

Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus

(2008) Inês M. Araújo et al.   JOURNAL OF NEUROCHEMISTRY

Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus

(2008) A. Ludanyi et al.   JOURNAL OF NEUROSCIENCE

Dual-target-directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease

(2008) Jacobus P. Petzer et al.   Neurotherapeutics

Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid

(2008) Ben Coomber et al.   SYNAPSE

Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning

(2007) P Pacher et al.   BRITISH JOURNAL OF PHARMACOLOGY

The complications of promiscuity: endocannabinoid action and metabolism

(2007) S P H Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: A critical revisitation

(2007) Giorgio Ortar et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY